News

At least 18% of income protection claims came from the financial, professional, and support services sector, Mangaliso ...
Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company dedicated to the discovery and development ...
If we haven't been touched by Alzheimer's directly, we know someone who has. In fact, more than 7 million Americans aged 65 ...
Applied Cognition, a clinical-stage platform therapeutic company, today announced the publication of a groundbreaking study ...
The report from RFK Jr. points to several culprits for chronic disease among children, including food additives and ...
Liberty announced its claims statistics for 2024 today, showing it paid out more than R12 billion in 2024 for 120 000 insured ...
The payments have raised concerns that doctors could be influenced to favour specific drugs or prescribe them over talking ...
Neither of them knows what to call it. But science does. Brain fog. They're not the only ones. In Kashmir, memory slips, ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders ...
The “Women in Translational Neuroscience” series of article collections, proposed by Frontiers in Neuroscience, is an initiative aimed at disclosing and ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM) has announced a settlement agreement with Hetero Labs Ltd. and its affiliates, ...